×

Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine

  • US 20060233770A1
  • Filed: 09/19/2003
  • Published: 10/19/2006
  • Est. Priority Date: 09/19/2002
  • Status: Active Grant
First Claim
Patent Images

1. A human cell line, which lacks major histocompatibility class I (MHC-I) antigens and major histocompatibility class II (MHC-II) antigens and which has been modified to comprise and express (i) a gene encoding an immunomodulator and (ii) a gene encoding an antigen of Epstein-Barr virus (EBV).

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×